SCHEMBL5366116

SCHEMBL5366116

CC(C)(C)OC(=O)c1ccc(O)c(C(C)(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 6/20 0.54
HSP90AB1 P08238 6/20 0.54
ESRRA P11474 2/20 0.53
NR1H4 Q96RI1 3/20 0.52
RARB P10826 2/20 0.49
RARG P13631 2/20 0.49
RARA P10276 1/20 0.49
ALDH1A1 P00352 2/20 0.48
NR1I2 O75469 1/20 0.48
LMNA P02545 1/20 0.48
CYP2C9 P11712 1/20 0.48
MIF P14174 1/20 0.48
TYR P14679 1/20 0.48
ALOX15 P16050 1/20 0.48
HTT P42858 1/20 0.48
NFE2L2 Q16236 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2310374 0.84 CA12 (0.65) HSP90AA1HSP90AB1ESRRANR1H4RARB
SCHEMBL39054 0.84 CA12 (0.63) ALDH1A1LMNAALOX15HTTHSD17B10
SCHEMBL1570461 0.81 CA12 (0.47) ALDH1A1LMNAALOX15HTTHSD17B10
SCHEMBL11611460 0.80 LMNA (0.50) ALDH1A1LMNATYRALOX15HTT
SCHEMBL5364276 0.80 CA12 (0.68) HSP90AA1HSP90AB1ESRRANR1H4RARB
SCHEMBL2609133 0.79 CA12 (0.50) ALDH1A1LMNAALOX15HTTHSD17B10
SCHEMBL31587898 0.79 CA12 (0.46) ALDH1A1LMNAMIFALOX15HTT
SCHEMBL1121892 0.79 ALOX15 (0.51) NR1H4ALDH1A1LMNAALOX15HTT
SCHEMBL10776576 0.79 ESR1 (0.55) ALDH1A1LMNAALOX15HTTHSD17B10
SCHEMBL384263 0.78 RARB (0.71) HSP90AA1HSP90AB1ESRRANR1H4RARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205409-B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBOTT LABORATORIES (US) 2007-04-17 US disclosed
US-20050131019-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBVIE INC. 2005-06-16 US disclosed
WO-2005023762-A1 PYRROLIDINE-2-CARBONITRILE DERIVATIVES AND THEIR USE AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) ABBOTT LABORATORIES (US) 2005-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131019-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) DPP4, DPP3, DPP7 HSP90AA1 3365/4885HSP90AB1 2858/4885ESRRA 3288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.